
Akhil Santhosh
Apr 9, 2025, 02:49
Akhil Santhosh: Toripalimab plus axitinib in patients with stage 4 mucosal melanoma
Akhil Santhosh, Medical Oncology Specialist at MVR Cancer Centre and Research Institute, shared a post on X:
“Toripalimab plus axitinib in patients with stage 4 mucosal melanoma: 3-year survival update and biomarker analysis
- 9pts phase data
- Median PFS 7.5m
- 3 year OS 3%
- gene GEP correlates with increased PFS and OS.”
Authors: Siming Li, Xiaowen Wu, Xieqiao Yan, Li Zhou, Zhihong Chi, Lu Si, Chuanliang Cui, Bixia Tang, Lili Mao, Bin Lian, Xuan Wang, Xue Bai, Jie Dai, Yan Kong, Xiongwen Tang, Hui Feng, Sheng Yao, Keith T Flaherty, Jun Guo, Xinan Sheng
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Apr 15, 2025, 17:17
Apr 15, 2025, 17:01
Apr 15, 2025, 16:16
Apr 15, 2025, 15:50
Apr 15, 2025, 15:31
Apr 15, 2025, 15:26